198 related articles for article (PubMed ID: 19385966)
1. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.
Goyama S; Kurokawa M
Cancer Sci; 2009 Jun; 100(6):990-5. PubMed ID: 19385966
[TBL] [Abstract][Full Text] [Related]
2. The role of EVI-1 in normal hematopoiesis and myeloid malignancies (Review).
Yuan X; Wang X; Bi K; Jiang G
Int J Oncol; 2015 Dec; 47(6):2028-36. PubMed ID: 26496831
[TBL] [Abstract][Full Text] [Related]
3. The human Evi-1 gene is located on chromosome 3q24-q28 but is not rearranged in three cases of acute nonlymphocytic leukemias containing t(3;5)(q25;q34) translocations.
Morishita K; Parganas E; Bartholomew C; Sacchi N; Valentine MB; Raimondi SC; Le Beau MM; Ihle JN
Oncogene Res; 1990; 5(3):221-31. PubMed ID: 2108405
[TBL] [Abstract][Full Text] [Related]
4. Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies.
Wieser R; Schreiner U; Rieder H; Pirc-Danoewinata H; Grüner H; Loncarevic IF; Fonatsch C
Haematologica; 2003 Jan; 88(1):25-30. PubMed ID: 12551823
[TBL] [Abstract][Full Text] [Related]
5. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.
Ogawa S; Kurokawa M; Tanaka T; Tanaka K; Hangaishi A; Mitani K; Kamada N; Yazaki Y; Hirai H
Leukemia; 1996 May; 10(5):788-94. PubMed ID: 8656673
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of leukemogenesis by AML1/EVI-1.
Mitani K
Oncogene; 2004 May; 23(24):4263-9. PubMed ID: 15156182
[TBL] [Abstract][Full Text] [Related]
7. The role of Runx1/AML1 and Evi-1 in the regulation of hematopoietic stem cells.
Kumano K; Kurokawa M
J Cell Physiol; 2010 Feb; 222(2):282-5. PubMed ID: 19847803
[TBL] [Abstract][Full Text] [Related]
8. The human thrombopoietin gene is located on chromosome 3q26.33-q27, but is not transcriptionally activated in leukemia cells with 3q21 and 3q26 abnormalities (3q21q26 syndrome).
Suzukawa K; Satoh H; Taniwaki M; Yokota J; Morishita K
Leukemia; 1995 Aug; 9(8):1328-31. PubMed ID: 7643620
[TBL] [Abstract][Full Text] [Related]
9. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
10. Evi-1 as a critical regulator of leukemic cells.
Goyama S; Kurokawa M
Int J Hematol; 2010 Jun; 91(5):753-7. PubMed ID: 20532840
[TBL] [Abstract][Full Text] [Related]
11. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB
Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414
[TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of Evi-1 gene in human leukemias.
Ogawa S; Mitani K; Kurokawa M; Matsuo Y; Minowada J; Inazawa J; Kamada N; Tsubota T; Yazaki Y; Hirai H
Hum Cell; 1996 Dec; 9(4):323-32. PubMed ID: 9183665
[TBL] [Abstract][Full Text] [Related]
13. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
[TBL] [Abstract][Full Text] [Related]
14. Evi-1 promotes para-aortic splanchnopleural hematopoiesis through up-regulation of GATA-2 and repression of TGF-b signaling.
Sato T; Goyama S; Nitta E; Takeshita M; Yoshimi M; Nakagawa M; Kawazu M; Ichikawa M; Kurokawa M
Cancer Sci; 2008 Jul; 99(7):1407-13. PubMed ID: 18452556
[TBL] [Abstract][Full Text] [Related]
15. Structurally altered Evi-1 protein generated in the 3q21q26 syndrome.
Ogawa S; Kurokawa M; Tanaka T; Mitani K; Inazawa J; Hangaishi A; Tanaka K; Matsuo Y; Minowada J; Tsubota T; Yazaki Y; Hirai H
Oncogene; 1996 Jul; 13(1):183-91. PubMed ID: 8700545
[TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of the evi-1 gene in the human factor-dependent leukemia cell line, UCSD/AML1.
Oval J; Smedsrud M; Taetle R
Leukemia; 1992 May; 6(5):446-51. PubMed ID: 1593910
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization studies using BAC clones of the EVI1 locus in hematological malignancies with 3q rearrangements.
Madrigal I; Carrió A; Gómez C; Rozman M; Esteve J; Nomdedeu B; Campo E; Costa D
Cancer Genet Cytogenet; 2006 Oct; 170(2):115-20. PubMed ID: 17011981
[TBL] [Abstract][Full Text] [Related]
18. EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements.
Poppe B; Dastugue N; Vandesompele J; Cauwelier B; De Smet B; Yigit N; De Paepe A; Cervera J; Recher C; De Mas V; Hagemeijer A; Speleman F
Genes Chromosomes Cancer; 2006 Apr; 45(4):349-56. PubMed ID: 16342172
[TBL] [Abstract][Full Text] [Related]
19. EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.
Konantz M; André MC; Ebinger M; Grauer M; Wang H; Grzywna S; Rothfuss OC; Lehle S; Kustikova OS; Salih HR; Handgretinger R; Fend F; Baum C; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
Leukemia; 2013 Jan; 27(1):56-65. PubMed ID: 22828445
[TBL] [Abstract][Full Text] [Related]
20. Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts.
Morishita K; Parganas E; Douglass EC; Ihle JN
Oncogene; 1990 Jul; 5(7):963-71. PubMed ID: 2115646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
